Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.52 |
| ▸ | CA2 | P00918 | 2/20 | 0.52 |
| ▸ | CA7 | P43166 | 2/20 | 0.52 |
| ▸ | CA9 | Q16790 | 2/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.52 |
| ▸ | ESR1 | P03372 | 1/20 | 0.50 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.50 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10112762 | 1.00 | CA1 (0.52) | CA1CA2CA7CA9CA12 | |
| SCHEMBL7938513 | 0.92 | NFE2L2 (0.52) | CA1CA2CA7CA9CA12 | |
| SCHEMBL9914241 | 0.92 | ACHE (0.60) | CA1CA2CA7CA9CA12 | |
| SCHEMBL18715511 | 0.92 | MAPT (0.51) | CA1CA2CA7CA9CA12 | |
| SCHEMBL12737709 | 0.92 | CA4 (0.50) | CA1CA2CA7CA9CA12 | |
| SCHEMBL19335942 | 0.90 | CA1 (0.42) | CA1CA2CA7CA9CA12 | |
| SCHEMBL7929343 | 0.90 | ESR2 (0.69) | CA1CA2CA7CA9CA12 | |
| SCHEMBL12277221 | 0.87 | ACHE (0.54) | CA1CA2CA7CA9CA12 | |
| SCHEMBL12260130 | 0.87 | ACHE (0.54) | CA1CA2CA7CA9CA12 | |
| SCHEMBL14191202 | 0.85 | NPSR1 (0.43) | CA1CA2CA7CA9HSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 180 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230338906-A1 | SEPARATION MEMBRANE | NITTO DENKO CORPORATION (JP) | 2023-10-26 | — | — | US | disclosed |
| WO-2023176172-A1 | POLYIMIDE RESIN PRECURSOR | 東京応化工業株式会社 | 2023-09-21 | — | — | WO | disclosed |
| US-20230244148-A1 | EUV RESIST UNDERLAYER FILM-FORMING COMPOSITION | NISSAN CHEMICAL CORPORATION (JP) | 2023-08-03 | — | — | US | disclosed |
| US-20230235115-A1 | ESTER COMPOUND AND RESIN COMPOSITION | AJINOMOTO CO., INC. (JP) | 2023-07-27 | — | — | US | disclosed |
| US-20230235115-A1 | ESTER COMPOUND AND RESIN COMPOSITION | AJINOMOTO CO., INC. (JP) | 2023-07-27 | — | — | US | disclosed |
| EP-4215262-A1 | SEPARATION MEMBRANE | NITTO DENKO CORPORATION (JP) | 2023-07-26 | — | — | EP | disclosed |
| US-20230146282-A1 | METAL ORGANIC FRAMEWORK, SEPARATION MEMBRANE, AND METHOD FOR PRODUCING METAL ORGANIC FRAMEWORK | NITTO DENKO CORPORATION (JP) | 2023-05-11 | — | — | US | disclosed |
| US-20230146282-A1 | METAL ORGANIC FRAMEWORK, SEPARATION MEMBRANE, AND METHOD FOR PRODUCING METAL ORGANIC FRAMEWORK | NITTO DENKO CORPORATION (JP) | 2023-05-11 | — | — | US | disclosed |
| US-20230130077-A1 | SEPARATION MEMBRANE | NITTO DENKO CORPORATION (JP) | 2023-04-27 | — | — | US | disclosed |
| US-20230130077-A1 | SEPARATION MEMBRANE | NITTO DENKO CORPORATION (JP) | 2023-04-27 | — | — | US | disclosed |
| US-20070218277-A1 | Adhesive Film, Flexible Metal-Clad Laminate, and Processes for Producing These | KANEKA CORPORATION (JP) | 2007-09-20 | — | — | US | disclosed |
| US-20070218277-A1 | Adhesive Film, Flexible Metal-Clad Laminate, and Processes for Producing These | KANEKA CORPORATION (JP) | 2007-09-20 | — | — | US | disclosed |
| US-7267883-B2 | Polyimide film and laminate having metal layer and same | KANEKA CORPORATION (JP) | 2007-09-11 | — | — | US | disclosed |
| US-7267883-B2 | Polyimide film and laminate having metal layer and same | KANEKA CORPORATION (JP) | 2007-09-11 | — | — | US | disclosed |
| US-20070196734-A1 | Ion-Conducting Polymers And Membranes Comprising Them | Johnson Matthey Hydrogen Technologies Limited (GB) | 2007-08-23 | — | — | US | disclosed |
| US-20070178323-A1 | Polyimide multilayer body and method for producing same | KANEKA CORPORATION (JP) | 2007-08-02 | — | — | US | disclosed |
| US-20070178323-A1 | Polyimide multilayer body and method for producing same | KANEKA CORPORATION (JP) | 2007-08-02 | — | — | US | disclosed |
| US-20070149727-A1 | Moisture-curable resin composition | THE YOKOHAMA RUBBER CO., LTD. (JP) | 2007-06-28 | — | — | US | disclosed |
| US-7229732-B2 | Imaging members with crosslinked polycarbonate in charge transport layer | XEROX CORPORATION (US) | 2007-06-12 | — | — | US | disclosed |
| US-20070105030-A1 | 1, 4-Benzodioxane sulfonic acid compound and use thereof as electron-acceptor material | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2007-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070105030-A1 | 1, 4-Benzodioxane sulfonic acid compound and use thereof as electron-acceptor material | USE1, SLC9A1, ELOVL1 | CA1 1202/4885CA2 1456/4885CA7 944/4885 |
| US-20230146282-A1 | METAL ORGANIC FRAMEWORK, SEPARATION MEMBRANE, AND METHOD FOR PRODUCING METAL ORGANIC FRAMEWORK | SLCO4C1, SLCO2B1, SLCO1A2 | CA1 280/4885CA2 61/4885CA7 399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.